Search research articles
Contact Us
Filters
Showing results (201-210 of 248) with videos related to
Page
of 25
Sort By:
The Oncologist
|
August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
The Journal of Clinical Investigation
|
April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Pedro Barata, Shuchi Gulati, Andrew Elliott, et al.
Cancer Discovery
|
July 25, 2025
Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancer
Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, et al.
Cancer Research Communications
|
January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
John R Lozada, Andrew Elliott, Mark G Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer
Evan Y Yu, Hongli Li, Celestia S Higano, et al.
Frontiers in Oncology
|
October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNA
Umang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
The Journal of Clinical Investigation
|
July 15, 2024
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
Shuchi Gulati, Pedro C Barata, Andrew Elliott, et al.
Journal of Pain and Symptom Management
|
May 5, 2025
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
Regina M Koch, Miguel Muniz, Candy S Peskey, et al.
Cell
|
June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 248) with videos related to
Sort By:
Page
of 25
The Oncologist
|
August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
The Journal of Clinical Investigation
|
April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Pedro Barata, Shuchi Gulati, Andrew Elliott, et al.
Cancer Discovery
|
July 25, 2025
Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancer
Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, et al.
Cancer Research Communications
|
January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
John R Lozada, Andrew Elliott, Mark G Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer
Evan Y Yu, Hongli Li, Celestia S Higano, et al.
Frontiers in Oncology
|
October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNA
Umang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
The Journal of Clinical Investigation
|
July 15, 2024
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
Shuchi Gulati, Pedro C Barata, Andrew Elliott, et al.
Journal of Pain and Symptom Management
|
May 5, 2025
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
Regina M Koch, Miguel Muniz, Candy S Peskey, et al.
Cell
|
June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Page
of 25